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A substantial proportion of hitherto unexplained re-
spiratory tract illnesses is associated with human
metapneumovirus (hMPV) infection. This virus also
was found in patients with severe acute respiratory
syndrome (SARS). To determine the dynamics and
associated lesions of hMPV infection, six cynomolgus
macaques (Macaca fascicularis) were inoculated
with hMPV and examined by pathological and viro-
logical assays. They were euthanized at 5 (n  2) or 9
(n  2) days post-infection (dpi), or monitored until
14 dpi (n  2). Viral excretion peaked at 4 dpi and
decreased to zero by 10 dpi. Viral replication was
restricted to the respiratory tract and associated with
minimal to mild, multi-focal erosive and inflamma-
tory changes in conducting airways, and increased
numbers of macrophages in alveoli. Viral expression
was seen mainly at the apical surface of ciliated epi-
thelial cells throughout the respiratory tract, and less
frequently in type 1 pneumocytes and alveolar mac-
rophages. Both cell tropism and respiratory lesions
were distinct from those of SARS-associated corona-
virus infection, excluding hMPV as the primary cause
of SARS. This study demonstrates that hMPV is a re-
spiratory pathogen and indicates that viral replica-
tion is short-lived, polarized to the apical surface, and
occurs primarily in ciliated respiratory epithelial
cells. (Am J Pathol 2004, 164:1893–1900)
A substantial proportion of hitherto unexplained respira-
tory tract illnesses in human beings is associated with
infection by a recently discovered paramyxovirus, provi-
sionally named human metapneumovirus (hMPV).1 It is
most closely related to avian pneumovirus type C (APV),
the etiological agent of rhinitis and sinusitis in turkeys.1,2
Human metapneumovirus was first identified in the Neth-
erlands, where serological studies indicate that it has
been circulating in the human population since at least
1958 and that most children are infected by 5 years of
age.1 Since its discovery in the Netherlands, hMPV infec-
tion also has been reported elsewhere in Europe,3–7
North America,8,9 Asia,10,11 and Australia.12 Respiratory
tract disease associated with hMPV infection occurs both
in children and adults, suggesting that hMPV is capable
of causing clinically important re-infection of individuals
later in life.3,8 Clinically, hMPV-associated disease in-
cludes rhinitis, pharyngitis, bronchitis, bronchiolitis, and
pneumonia, and resembles that of human respiratory
syncytial virus (RSV) infection.13 Severity of disease var-
ies from common cold to death, with very young children,
the elderly, and immunocompromised patients being
predisposed to severe lower respiratory tract disease.13
In the recent epidemic of severe acute respiratory
syndrome (SARS), the role of hMPV as a primary patho-
gen or co-pathogen was considered.14 Although a newly
discovered virus, SARS-associated coronavirus (SCV),
proved to be the primary cause of the disease,15,16 12%
(41 of 335) of SARS patients also were infected with
Supported in part by the Sophia Foundation for Medical Research. R.F. is
a fellow of the Royal Dutch Academy of Arts and Sciences.
T.K. and B.G.V.D.H. contributed equally to this work.
Accepted for publication March 2, 2004.
Address reprint requests to Thijs Kuiken, Department of Virology, Eras-
mus Medical Center, P.O. Box 1738, 3000 DR Rotterdam, the Nether-
lands. E-mail: t.kuiken@erasmusmc.nl.
American Journal of Pathology, Vol. 164, No. 6, June 2004
Copyright © American Society for Investigative Pathology
1893
hMPV,17 so that the role of hMPV as a co-pathogen
cannot be ruled out at this time.
Until now, pathological confirmation that hMPV is a
primary respiratory pathogen is lacking.18 Diagnosis of
hMPV as the etiological agent of respiratory illness in the
above studies was based on virus isolation, reverse tran-
scription-polymerase chain reaction (RT-PCR), serocon-
version to hMPV, or a combination of these methods,
combined with the failure to detect other known respira-
tory pathogens. To characterize the virus excretion, virus
distribution, and associated lesions of hMPV infection,
and to determine whether they differ from those of SCV
infection, we experimentally inoculated six cynomolgus
macaques (Macaca fascicularis) with the prototype hMPV
isolate NL/1/002. They were euthanized at 5 (n  2) or 9
(n 2) days post-infection (dpi), or monitored until 14 dpi
(n  2). Here, we report the pathological, immunohisto-
chemical, virological, serological, and molecular biolog-
ical findings of this experiment.
Materials and Methods
Virus Preparation
The prototype hMPV isolate NL/1/002 was propagated
three times on tertiary monkey kidney (tMK) cells and
used to make a virus stock on tMK cells as previously
described.1 Virus was harvested 7 dpi and frozen in 25%
sucrose at 70°C. The infectious virus titer of this stock
was 104.5 median tissue culture infective dose (TCID50)
per ml by titration on tMK cells.
Experimental Protocol
Five days before infection, six juvenile cynomolgus ma-
caques were placed in a negatively pressurized glove
box in pairs of one male and one female. They were
provided with commercial food pellets and water ad libi-
tum. These macaques were colony-bred and had been
maintained in group housing, where they were screened
annually, and tested negative, for the following infections:
simian virus 40, polyomavirus, tuberculosis, measles vi-
rus, mumps, simian immunodeficiency virus, simian ret-
rovirus type D, and simian T-cell leukemia virus. Before
infection, they were examined clinically and determined
as healthy by a registered veterinarian. The macaques
were infected with 5.0  104 TCID50 of hMPV, which was
suspended in 5 ml of phosphate-buffered saline (PBS).
Approximately 4 ml was applied intratracheally by use of
a catheter, 0.5 ml on the tonsils, and 0.25 ml on each of
the conjunctivae.
The macaques were observed daily for the occurrence
of malaise, coughing, exudate from the eyes or nose,
forced respiration, and any other signs of illness. Ma-
caques No. 1 and No. 2 were euthanized at 5 dpi and
macaques No. 3 and No. 4 at 9 dpi by exsanguination
under ketamine anesthesia, while macaques No. 5 and
No. 6 were monitored until 14 dpi. Macaques No. 5 and
No. 6 were subsequently used for a follow-up experiment,
not described here. The body temperatures of macaques
No. 5 and No. 6 were measured by telemetry (IMAG,
Wageningen, the Netherlands) every 3 minutes. To this
end, a transponder was placed in their abdomens 30
days before inoculation.
Just before infection and daily from 2 dpi until eutha-
nasia or 10 dpi, the macaques were anesthetized with
ketamine and pharyngeal swabs were collected in 1 ml
transport medium19 and stored at 70°C until RT-PCR
and/or virus isolation. In addition, blood was collected
from an inguinal vein just before infection in all macaques
and at 14 dpi in macaques No. 5 and No. 6. Blood
samples were collected in EDTA tubes and centrifuged at
2500  g for 15 minutes, the plasma was collected and
stored at 70°C until immunofluorescence assay. All an-
imal procedures were approved by our institutional Ani-
mal Care and Use Committee.
Pathological Examination
Necropsies were carried out according to a standard
protocol. Samples for histological examination were
stored in 10% neutral-buffered formalin (lungs after infla-
tion with formalin), embedded in paraffin, sectioned at 4
m, and stained with hematoxylin and eosin (H & E) for
examination by light microscopy. The following tissues
were examined by light microscopy: adrenal gland, brain
stem, cerebellum, cerebrum, heart (left and right ventri-
cle), kidney, larynx, lung (left and right, cranial, medial,
and caudal lobes), liver, nasal septum (posterior section
covered by respiratory epithelium), pancreas, primary
bronchus (left and right), small intestine, spleen, stom-
ach, tonsil, trachea, tracheo-bronchial lymph node, up-
per eyelid (left and right), and urinary bladder. Tissue
sections of a clinically healthy juvenile male cynomolgus
macaque that had not been infected with hMPV were
used as a negative control.
Immunohistochemistry
Formalin-fixed, paraffin-embedded, 4-m thick sections
of the same tissues examined by light microscopy were
stained using an immunoperoxidase method. Tissue sec-
tions were mounted on coated slides (Klinipath, Duiven,
the Netherlands), deparaffinized, rehydrated, and boiled
for 15 minutes in citric acid buffer (10 mmol/L, pH 6.0)
using a microwave oven. Endogenous peroxidase was
revealed with 4-chloro-1-naphthol (Sigma Chemical Co.,
St. Louis, MO), yielding a blue-black precipitate. Sections
were subsequently washed with PBS containing 0.05%
Tween 20 (Fluka, Chemie AG, Buchs, Switzerland) and
incubated with a polyclonal guinea pig antiserum (dilu-
tion 1:200) to hMPV prepared as described previously1 or
with a negative control guinea pig serum for 1 hour at
room temperature. After washing, sections were incu-
bated with a horseradish peroxidase (HRP)-labeled rab-
bit-anti-guinea pig Ig (DAKO, Glostrup, Denmark) for 1
hour at room temperature. HRP activity was revealed by
incubating the sections in 3-amino-9-ethylcarbazole
(Sigma Chemical Co.) solution for 10 minutes, resulting in
a red precipitate. Sections were counterstained with he-
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matoxylin. Formalin-fixed, paraffin-embedded tMK cells
infected with hMPV were included as a positive control.
Tissue sections of a clinically healthy juvenile male cyno-
molgus macaque that had not been infected with hMPV
were used as a negative control. Selected lung sections
were stained with monoclonal antibody AE1/AE3 (Neo-
markers, Fremont, CA) for the identification of epithelial
cells according to standard immunohistochemical proce-
dures.
RT-PCR
Tissue samples of brain, heart, kidney, lung (cranial and
caudal lobes), liver, nasal septum, primary bronchus,
spleen, tonsil, trachea, and tracheo-bronchial lymph node
were weighed and homogenized in minimal essential me-
dium (10 ml per g tissue; Biowhittaker, Verviers, Belgium) by
use of Potter tissue grinders (Fisher Scientific, ’s-Hertogen-
bosch, the Netherlands). The homogenates were incubated
with lysis buffer (2 ml per ml homogenate; Roche Diagnos-
tics, Almere, the Netherlands) containing proteinase K for 1
hour at room temperature, and RNA was isolated by use of
a High Pure RNA Isolating kit (Roche Diagnostics) accord-
ing to the manufacturer’s instructions, resulting in 50 l
RNA. RNA was isolated from 200 l of transport medium
from the pharyngeal swabs according to the same method.
A Taqman real-time PCR developed in-house20 was per-
formed in triplicate on 5 l of isolated RNA from each
sample, using serial dilutions of a titrated stock of the same
virus as the calibration curve. The virus titer was expressed
as TCID50 per mg tissue or ml transport medium from pha-
ryngeal swabs.
Virus Isolation
Virus isolation on pharyngeal swabs was performed on
Vero cells, clone 118, in the absence of fetal calf serum in
the presence of 0.02% trypsin and 0.3% bovine albumin
Fraction V (Invitrogen, Groningen, the Netherlands). The
Vero-118 cell line, developed in-house, has equal sus-
ceptibility and sensitivity to all known genetic lineages of
hMPV. The Vero-118 cells had been grown in Iscove’s
Modified Dulbecco’s medium (Biowhittaker) supple-
mented with 10% fetal calf serum (Biowhittaker) and 2
mmol/L glutamine (Biowhittaker). The identity of the virus
was confirmed by RT-PCR and automatic sequencing.21
Immunofluorescence Assay
Ninety-six-well plates coated with Vero-118 cells and in-
fected with hMPV NL/1/00 were incubated with serial
dilutions (up to 1:64) of plasma samples for 1 hour at
37°C. After washing with PBS, plates were incubated with
fluorescein isothiocyanate-labeled anti-human IgG
(DAKO, 1:60) for 1 hour at 37°C. After washing with PBS
and background staining with eriochrome black (Sigma
Chemical Co.) for 1 minute, plates were read under an
ultraviolet microscope. Non-infected Vero-118 cells were
used as a negative control. Titers were expressed as the
reciprocal of the last positive dilution.
Results
Clinical Findings
Rhinorrhea was seen in macaque No. 4 and No. 5 at 8
dpi. No clinical signs, including increased body temper-
atures in macaques No. 5 and No. 6, were seen in the
other macaques.
Gross Pathology
Inspissated purulent exudate was present in the nasal
cavity of macaques No. 2 and No. 4. In the former, the
lining mucosa was reddened. Macaque No. 4 had aspi-
rated food remains immediately before euthanasia and
was excluded from further laboratory examination be-
cause histological lesions of hMPV infection were
masked and aspirated debris reacted non-specifically by
immunohistochemistry. No other gross lesions were seen
in these two macaques or in the other macaques.
Histopathology
Macaques No. 1 to No. 3 had a mild rhinitis, character-
ized in the epithelium by loss of ciliation, architectural
disruption, intra- and intercellular edema, and transmi-
gration of a few neutrophils (Figure 1B). There was
edema and infiltration with a few neutrophils in the under-
lying submucosa.
All three macaques had minimal multi-focal lesions in
the conducting airways, variable in extension from larynx
to bronchioles (Table 1; Figure 1, D to G). Epithelial
lesions consisted of loss of ciliation, architectural disrup-
tion, erosion, intercellular edema, and transmigration of
neutrophils. There was infiltration with a few neutrophils in
the underlying submucosa. The lumen of some bronchi
contained a few sloughed ciliated epithelial cells ad-
mixed with scant cellular debris and mucus. The lumen of
some bronchioles contained a few alveolar macro-
phages, rare multinucleated giant cells and neutrophils,
admixed with scant cellular debris and fibrin. Similar
material was present in the alveoli around affected bron-
chioles. No significant histological changes were seen in
sections of other tissues examined. Above lesions were
not seen in the tissues of the negative control macaque.
Immunohistochemistry
Expression of hMPV occurred mainly in ciliated respira-
tory epithelium from the nasal cavity to the bronchioles in
both macaques euthanized at 5 dpi, but not in the ma-
caque euthanized at 9 dpi (Table 1; Figure 2, A to C). It
occurred multi-focally in individual or groups of adjacent
ciliated epithelial cells, and was seen both in morpholog-
ically normal (Figure 2B) and in degenerate or sloughed
ciliated cells (Figure 2A). Expression of hMPV was visible
as dark red staining of the cilia and apical plasma mem-
brane, and diffuse lighter red staining of the cytoplasm.
Neither goblet cells nor basal cells stained positively,
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even where they were located immediately adjacent to
positively staining ciliated cells.
Expression of hMPV occurred occasionally in alveoli of
all three macaques (Figure 2, D to F). It occurred multi-
focally in type 1 pneumocytes, individual or small clusters
of adjacent alveolar macrophages, and in intraluminal
cellular debris. Expression in type 1 pneumocytes was
visible as diffuse cytoplasmic staining (Figure 2, D and
Figure 1. Histopathology of experimental human metapneumovirus infection in cynomolgus macaques. A: Section of respiratory mucosa from nasal septum of
negative control macaque. The pseudo-stratified epithelium consists of ciliated cells with cilia on apical surface, goblet cells with clear cytoplasm, and basal cells
lying on the basement membrane. (H&E, original magnification, 100). B: Section of respiratory mucosa from nasal septum of macaque No. 1. Suppurative
rhinitis. There is loss of cilia, intercellular edema, architectural disruption, erosion, and infiltration with many neutrophils in the epithelium and submucosa. (H&E,
original magnification, 100). C: Section of tracheal mucosa of negative control macaque. The pseudo-stratified epithelium has the same constituent cells as in
panel A. (H&E, original magnification, 250). D: Tracheal section of macaque No. 1. Suppurative tracheitis. There is multi-focal loss of cilia, intercellular edema,
architectural disruption, and infiltration with a few neutrophils in the epithelium and submucosa. (H&E, original magnification, 250). E: Pulmonary section of
macaque No. 3. Bronchiolitis. The bronchiolar lumen (arrowhead) is partly filled with macrophages. An increased number of macrophages also is present in
alveolar lumina (arrows) adjacent to the bronchiole. (H&E, original magnification 25). F: Pulmonary section of macaque No. 3. Erosive bronchiolitis. There is
loss of bronchiolar epithelium, and the bronchiolar lumen is filled with macrophages. (H&E, original magnification, 100). G: Pulmonary section of macaque No.
3. Erosive bronchiolitis. Detail of panel F. Cuboidal cells (arrowheads) line the bronchiolar wall. The bronchiolar wall in between the arrowheads is denuded.
(H&E, original magnification, 250).
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E). These cells were identified as type 1 pneumocytes
because they lined the alveolar walls, were squamous, and
expressed keratin in serial sections. In alveolar macro-
phages, it consisted of multiple distinct dark red granules in
the cytoplasm (Figure 2F). Multinucleated giant cells did not
stain positively. No positive staining was observed in any of
the other tissues examined, nor in tissues of the negative
control macaque (Figure 2, G and H).
RT-PCR and Virus Isolation
After an incubation period of 2 days at most, excretion of
hMPV increased rapidly to a peak of 1.3  106 TCID50/ml
at 4 dpi, and then decreased gradually to zero at 10 dpi
(Figure 3). The results of RT-PCR were confirmed by virus
isolation: hMPV was re-isolated from pharyngeal swabs
collected at the peak of virus excretion of all six ma-
caques.
At necropsy, hMPV was detected by RT-PCR through-
out the respiratory tract, from the nasal cavity to the
lungs, and virus titers were generally higher at 5 dpi than
at 9 dpi (Table 1). The virus titers (mean SD TCID50 per
mg tissue) in the tonsil (26  6.4 in macaque No. 1, 14 
3.2 in macaque No. 2, and 0 in macaque No. 3) and
tracheo-bronchial lymph node (192 42 in macaque No.
1, 2.1 0.7 in macaque No. 2, and 3.2 2.5 in macaque
No. 3) corresponded to this temporal pattern. Human
metapneumovirus was not detected by RT-PCR in brain,
heart, kidney, liver, or spleen of any of the macaques.
Immunofluorescence Assay
Before inoculation, anti-hMPV antibodies were not de-
tected in plasma samples of any of the six macaques. At
14 dpi, both macaques No. 5 and No. 6 had serocon-
verted with an anti-hMPV antibody titer of 64.
Discussion
This experimental infection confirms that hMPV is a pri-
mary pathogen of the upper and lower respiratory tract in
cynomolgus macaques. Clinical signs in hMPV-infected
macaques were limited to rhinorrhea, and corresponded
with a suppurative rhinitis at pathological examination.
Additional histological lesions in the respiratory tract were
minimal to mild erosive and inflammatory changes in
mucosa and submucosa of conducting airways, and an
increased number of alveolar macrophages in bronchi-
oles and pulmonary alveoli. The close association be-
tween the respiratory lesions and the specific expression
of hMPV antigen by immunohistochemistry, together with
the absence of these lesions in the negative control tis-
sues, support our conclusion that hMPV infection was the
cause of these lesions.
Based on expression of hMPV by immunohistochem-
istry, viral replication in ciliated epithelial cells was wide-
spread throughout the respiratory tract and more spo-
radic in type 1 pneumocytes. Viral antigen also was
detected in alveolar macrophages, but the distinct gran-
ular character of cytoplasmic staining suggests phago-
cytosis of viral material rather than viral replication. The
strong reduction in the distribution of hMPV-infected cells
in the respiratory tract between 5 and 9 dpi (Table 1)
corresponds with the reduction in viral excretion, as mea-
sured by RT-PCR, from the peak at 4 dpi to zero by 10 dpi
(Figure 3). If possible, these immunohistochemical re-
sults should be substantiated with a larger number of
animals. The absence of hMPV expression by immuno-
histochemistry in other tissues indicates that hMPV rep-
lication is restricted to the respiratory tract. The above
conclusions were corroborated by the results of virus
isolation and RT-PCR.
These findings substantiate the claim of van den Hoo-
gen et al1 that hMPV infection causes respiratory tract
illness in human beings. The subclinical or mild character
of the disease associated with hMPV infection in these
macaques corresponds to that in immunocompetent mid-
dle-age adults.13 Based on the ability of hMPV to repli-
cate in the bronchioles and alveoli of cynomolgus ma-
caques, one may expect more extensive viral replication
and an associated increased severity of lesions in the
lower respiratory tract of immunocompromised human
beings, resulting in the severe bronchiolitis and pneumo-
nia diagnosed clinically in such patients.22,23
The predominant tropism of hMPV for ciliated epithelial
cells in the conducting airways and the mildness of the
associated lesions, as seen in this study, contrasts with the
predilection of SCV for alveolar epithelial cells and the se-
verity of the associated pneumonia in SARS patients15,24–26
and experimentally infected macaques.16,17 These differ-
ences confirm that SCV and not hMPV is the primary etio-
logical agent of SARS.
Table 1. Microscopic Lesions and Presence of hMPV Antigen in Various Tissues of the Respiratory Tract of Cynomolgus






Evidence of lesions by histology (HI) or of hMPV by immunohistochemistry (IHC) or RT-PCR in the
respiratory tract
Nasal septum Trachea Bronchus Cranial lung Caudal lung
HI IHC PCR HI IHC PCR HI IHC PCR HI IHC PCR HI IHC PCR
1 5 *  73  9.5†   377  41   1675  32   32  9.3   73  18
2 5   47  5.8 ‡  4  1.7   98  16   115  30   68  7.4
3 9   5  2.3   0  0.2   25  7.8   45  5.9   15  7.5
*Positive.
†Mean  standard deviation TCID50/mg tissue.
‡Negative.
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Figure 2. Immunohistochemistry of experimental human metapneumovirus (hMPV) infection in cynomolgus macaques. A: Section of respiratory mucosa from
nasal septum of macaque No. 2. Expression of hMPV occurs in the cytoplasm of degenerate epithelial cells and in cell debris. (Immunoperoxidase stain for hMPV,
original magnification, 100). B: Bronchial section of macaque No. 1. Expression of hMPV occurs in the cytoplasm of morphologically normal ciliated epithelial
cells. (Immunoperoxidase stain for hMPV, original magnification, 100). C: Bronchial section of macaque No. 1. Detail of panel B. Expression of hMPV is most
pronounced in the cilia and apical plasma membrane of ciliated epithelial cells. Mucus cells and basal cells stain negative. (Immunoperoxidase stain for hMPV,
original magnification, 250). D and E: Pulmonary section of macaque No. 1. Expression of hMPV occurs diffusely in the cytoplasm of type 1 pneumocytes lining
the alveolar walls. (Immunoperoxidase stain for hMPV, original magnification, 250). F: Pulmonary section of macaque No. 1. Expression of hMPV occurs in the
cytoplasm of alveolar macrophages and in intraluminal cell debris. Staining of alveolar macrophages is multi-focal and granular. (Immunoperoxidase stain for
hMPV, original magnification, 250). G: Bronchial section of negative control macaque. There is no expression of hMPV. (Immunoperoxidase stain for hMPV;
original magnification, 250). H: Pulmonary section of negative control macaque. There is no expression of hMPV. (Immunoperoxidase stain for hMPV, original
magnification, 250).
1898 Kuiken et al
AJP June 2004, Vol. 164, No. 6
The pathogenesis of hMPV infection in macaques is
similar in many ways to that of RSV in human beings, as
far as it has been studied. As in hMPV, incubation period
and excretion period are short, although RSV excretion
may be prolonged in infants and immunocompromised
individuals.27 Both initial infection and subsequent shed-
ding of RSV are restricted to ciliated epithelial cells,
based on an in vitro study using recombinant RSV ex-
pressing green fluorescent protein.28 Similar to the local-
ization of RSV in that study, the results of immunohisto-
chemistry in these macaques show that hMPV infection is
polarized to the apical surface of ciliated respiratory ep-
ithelium. In immunocompetent individuals, the most com-
mon clinical manifestation of RSV infection is mild upper
respiratory tract disease.29 However, viral distribution
and associated lesions of this mild disease have not been
reported. In very young or immunocompromised individ-
uals, RSV replication occurs in epithelial cells of bron-
chus, bronchiole, and in alveolar macrophages,30,31 and
is associated with severe bronchiolitis, interstitial pneu-
monia, or giant cell pneumonia.32 Although clinical stud-
ies indicate that hMPV infection may cause similar lesions
in this category of patients, confirmation of fatal bronchi-
olitis or pneumonia from hMPV infection awaits patholog-
ical assessment of biopsy or autopsy samples.18
The pathogenesis of hMPV infection also is similar to
that of APV, its closest known relative.2 As for hMPV
infection in cynomolgus macaques, APV infection in tur-
keys has a short incubation and excretion period (2 and
8 days, respectively), occurs primarily in ciliated respira-
tory epithelial cells, and is associated with superficial
erosive and inflammatory changes. In contrast to hMPV
infection, APV antigen is not present in alveolar macro-
phages or alveolar walls. However, this difference may
be explained, at least in part, by the intratracheal appli-
cation of hMPV in macaques (this study) compared to the
conjunctival and intranasal application of APV in experi-
mentally infected turkeys.33
The results of this study provide the first characteriza-
tion of the viral excretion, viral distribution and associated
lesions of hMPV infection in cynomolgus macaques, and
help to understand the pathology of this infection in hu-
man beings. The immunohistochemical method de-
scribed above may be useful for retrospective analysis of
respiratory tissues of human patients with respiratory dis-
ease of unknown viral origin, and to study the possible
role of hMPV as a co-pathogen in patients with SARS.
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